← Research library

N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity.

Lab research · 2026

What was studied
Mouse HT-22 and human SH-SY5Y cell lines
Main finding
GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.

Study data at a glance

Participants or experimental model
Mouse HT-22 and human SH-SY5Y cell lines
Reported results
GZS-411 activated TrkB and protected cultured cells against oxidative stress, glutamate toxicity and 6-hydroxydopamine. The study does not establish animal or human treatment effects.
Study limitations and source details

Study limitations

  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

In vitroEnglish abstract

Gudasheva TA, Sokolenko NI, Kolyasnikova KN, Antipova TA, Zainullina LF, Sergeeva MS, Dorofeev VL. N-Isocaproyl-L-Arginylglycine Hexamethylenediamide, First Low-Molecular-Weight Mimetic of Neurotrophin-4: Design and Neuroprotective Activity. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections

Study source ↗ · DOI 10.1134/s0012496626600156 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards